Myasthenia Gravis
📧 Sign up to get email alerts when something new happens for Myasthenia Gravis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Efficacy and Safety of Sugammadex in Thoracoscopy Thymectomy for Chinese Adults With Myasthenia Gravis [NA]
A completed clinical trial evaluated the efficacy and safety of sugammadex for reversing neuromuscular blockade during thoracoscopy thymecto…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Digital Phenotyping and Lifestyle Intervention in Patients with Myasthenia Gravis [NA]
This clinical trial update notes the completion of a study exploring digital phenotyping and lifestyle intervention in patients with Myasthe…
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment
A completed proof-of-concept clinical trial evaluating a social-media-targeted, self-assessment approach to speed up diagnostic evaluation f…
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: Descriptive Analysis of Real-world Data Collected with ME&MGopen
This clinical trial update presents a descriptive analysis of real-world data collected with ME&MGopen in patients with myasthenia gravis.
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Biomarkers for Fatigue in Patients with Myasthenia Gravis
A completed clinical trial update reporting on biomarkers associated with fatigue in patients with Myasthenia Gravis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Artificial Intelligence for the Analysis of Video Data of Facial Movement, with a Focus on Myasthenia Gravis
A clinical trial sponsored by Leiden University Medical Center evaluating artificial intelligence analysis of facial movement in Myasthenia …
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis [Phase 2]
The Phase 2 trial of ALXN2050 in adults with generalized myasthenia gravis was terminated. Results from the study have been posted.
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Pilot Study: Use of the Saccadometer to Detect Characteristic Saccadic Peak Velocity in Myasthenia Gravis Patients [NA]
This completed pilot study evaluated whether the Saccadometer can detect characteristic saccadic peak velocity in patients with Myasthenia G…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Characteristics and Prognostic Outcomes of Diaphragmatic Ultrasound in Myasthenia Gravis
An update on an active, not-recruiting clinical study evaluating diaphragmatic ultrasound for prognostic outcomes in myasthenia gravis. The …
-
CLINICAL_TRIALS trial_result · 2024-10-26Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Rituximab in Patients With Myasthenia Gravis [Phase 3]
A Phase 3 study evaluating rituximab for generalized myasthenia gravis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Interval Inspiratory Training and Aerobic Exercise for Muscle Recovery in Myasthenia Gravis Post-Hospitalization [NA]
A completed clinical trial evaluated interval inspiratory training and aerobic exercise for muscle recovery in myasthenia gravis after hospi…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: The Risk of Falls Index for Patients With Neuromuscular Disorders
A completed trial evaluating a Falls Index to assess fall risk in patients with neuromuscular disorders, including Inclusion Body Myositis, …
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: The Impact of Myasthenia Gravis in the Real World
This document reports on a completed clinical trial assessing the real-world impact of Myasthenia Gravis.
-
CLINICAL_TRIALS trial_result · 2024-04-08Clinical Trial Update: Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis [Phase 3]
Phase 3 trial of tolebrutinib for generalized myasthenia gravis was terminated, but efficacy and safety results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: A Study of RVT-1401 in Myasthenia Gravis (MG) Patients [Phase 2]
Phase 2 trial of RVT-1401 in Myasthenia Gravis has been completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-07-14Clinical Trial Update: A Safety and Tolerability Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness. [Phase 3]
Phase 3 trial update on ARGX-113 in generalized myasthenia gravis reports safety and tolerability findings.
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: Pyridostigmine and Amifampridine for Myasthenia Gravis [Phase 3]
Phase 3 clinical trial update for pyridostigmine and amifampridine in myasthenia gravis is in UNKNOWN status.
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: A Study of TAK-079 in People With Generalized Myasthenia Gravis [Phase 2]
Phase 2 clinical trial update for TAK-079 in generalized myasthenia gravis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients [Phase 3]
Phase 3 trial evaluating the efficacy and safety of HBM9161 (HL161) subcutaneous injection in generalized myasthenia gravis has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis [Phase 3]
Phase 3 trial update on the safety of HBM9161 (HL161) given subcutaneously in generalized myasthenia gravis.
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients [Phase 2]
Phase 2 clinical trial evaluating efficacy, safety, pharmacodynamics and pharmacokinetics of HBM9161 in patients with Myasthenia Gravis has …
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG) [Phase 3]
A Phase 3 pilot trial evaluating subcutaneous immunoglobulin (SCIG) in patients with Myasthenia Gravis exacerbation has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-25Clinical Trial Update: A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG) [Phase 3]
Phase 3 open-label study of eculizumab in pediatric patients with refractory generalized myasthenia gravis completed; results posted in 2022…
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: Efficacy and Safety of Low-dose Rituximab in the Treatment of Refractory Myasthenia Gravis [Phase 3]
Phase 3 trial evaluating low-dose rituximab for efficacy and safety in refractory myasthenia gravis.
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy [Phase 3]
Phase 3 trial assessing lef lunomide or azathioprine therapy in myasthenia gravis patients after thymectomy; completed study.